Key statistics
As of last trade Lonza Group AG (LO3A:FRA) traded at 55.50, -9.76% below its 52-week high of 61.50, set on Aug 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 55.50 |
---|---|
High | 55.50 |
Low | 55.50 |
Bid | 55.50 |
Offer | 57.50 |
Previous close | 55.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 0.4047 EUR |
---|---|
Annual div yield (ADY) | 0.74% |
Div ex-date | May 15 2024 |
Div pay-date | May 29 2024 |
Data delayed at least 15 minutes, as of Nov 22 2024 07:16 GMT.
More ▼
- Lonza to Expand Bioconjugation in Visp (CH) with Two Additional Manufacturing Suites
- Q3 2024 Qualitative Update: Lonza Confirms Full-Year Outlook 2024
- Lonza Extends Collaboration with Major Pharmaceutical Partner for Integrated Commercial Supply of Antibody-Drug Conjugates
- Lonza Nominates David Meline as Independent Board Member
- Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche
- Lonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel)
- Lonza Prices EUR 1.2 Billion Dual-Tranche Straight Bonds
More ▼